Expression of cyclooxygenase-2 and vascular endothelial growth factor in ovarian endometriotic cysts and their relationship with angiogenesis

Fertility and Sterility

Volumn 90, Issue 4, 2008, Pages 988-993

  Ceyhan, Seyit Temel ^a   Onguru, Onder ^a   Baser, Iskender ^a   Gunhan, Omer ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

angiogenesis; cyclooxygenase 2; immunohistochemistry; microvessel density; Ovarian endometriosis; vascular endothelial growth factor

Indexed keywords

CYCLOOXYGENASE 2; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MICROVASCULATURE; OUTCOME ASSESSMENT; OVARY CYST; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; CYCLOOXYGENASE 2; ENDOMETRIOSIS; FEMALE; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN CYSTS; OVARY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 52949144272     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.07.1332     Document Type: Article

References (32)

1. Ranney B. Endometriosis: pathogenesis, symptoms, and findings. Clin Obstet Gynecol 23 (1980) 865-874
2. Abulafia O., and Sherer D.M. Angiogenesis of the endometrium. Obstet Gynecol 94 (1999) 148-153
3. Healy D.L., Rogers P.A., Hii L., and Wingfield M. Angiogenesis: a new theory for endometriosis. Hum Reprod Update 4 (1998) 736-740
4. Smith W.L., Garavito R.M., and De Witt D.L. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 271 (1996) 33157-33160
5. Dubious R.N., Abramson S.B., Crofford L., Gupta R.A., Simon L.S., Van de Putte L.B.A., et al. Cyclooxygenase in biology and disease. FASEB J 12 (1998) 1063-1073
6. Kirkpatrick K., Ogunkolade W., Elkak A., Bustin S., Jenkins P., Ghilchik M., et al. The mRNA expression of cyclooxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) in human breast cancer. Curr Med Res Opin 18 (2002) 237-241
7. McLaren J. Vascular endothelial growth factor and endometriotic angiogenesis. Hum Reprod Update 6 (2000) 45-55
8. Matsuzaki S., Canis M., Darcha C., Dallel R., Okamura K., and Mage G. Cyclooxygenase-2 selective inhibitor prevents implantation of eutopic endometrium to ectopic sites in rats. Fertil Steril 82 (2004) 1609-1615
9. Ota H., Igarashi S., Sasaki M., and Tanaka T. Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis. Hum Reprod 16 (2001) 561-566
10. Chishima F., Hayakawa S., Sugita K., Kinukawa N., Aleemuzzaman S., Nemoto N., et al. Increased expression of cyclooxygenase-2 in local lesions of endometriosis patients. Am J Reprod Immunol 48 (2002) 50-56
11. Weidner N., Semple J.P., Welch W.R., and Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324 (1991) 1-8
12. Weidner N., Folkman J., Pozza F., Bevilacqua P., Allred E.N., Moore D.H., et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84 (1992) 1875-1887
13. Hansen S., Grabau D.A., Rose C., Bak M., and Sørensen F.B. Angiogenesis in breast cancer. A comparative study of the observer variability of methods for determining microvessel density. Lab Invest 78 (1998) 1563-1573
14. Donnez J., Smoes P., Gillerot S., Casanas-Roux F., and Nisolle M. Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod 13 (1998) 1686-1690
15. Nisolle M., Casanas-Roux F., Anaf V., Mine J.M., and Donnez J. Morphometric study of the stromal vascularization in peritoneal endometriosis. Fertil Steril 59 (1993) 681-684
16. Hii L.L., and Rogers P.A. Endometrial vascular and glandular expression of integrin alpha(v)beta3 in women with and without endometriosis. Hum Reprod 13 (1998) 1030-1035
17. Kim S.H., Choi Y.M., Chae H.D., Kim K.R., Kim C.H., and Kang B.M. Increased expression of endoglin in the eutopic endometrium of women with endometriosis. Fertil Steril 76 (2001) 918-922
18. Goteri G., Lucarini G., Filosa A., Pierantoni A., Montik N., Biagini G., et al. Immunohistochemical analysis of vascular endothelial growth factor cellular expression in ovarian endometriomata. Fertil Steril 81 (2004) 1528-1533
19. Oosterlynck D.J., Meuleman C., Sobis H., Vandeputte M., and Koninckx P.R. Angiogenic activity of peritoneal fluid from women with endometriosis. Fertil Steril 59 (1993) 778-782
20. McLaren J., Prentice A., Charnock-Jones D.S., and Smith S.K. Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum Reprod 11 (1996) 220-223
21. Tan X.J., Lang J.H., Liu D.Y., Shen K., Leng J.H., and Zhu L. Expression of vascular endothelial growth factor and thrombospondin-1 mRNA in patients with endometriosis. Fertil Steril 78 (2002) 148-153
22. Kupker W., Schultze-Mosgau A., and Diedrich K. Paracrine changes in the peritoneal environment of women with endometriosis. Hum Reprod Update 4 (1998) 719-723
23. Williams C.S., Tsujii W., Reese J., Dey S.K., and DuBois R.N. Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest 105 (2000) 1589-1594
24. Matsuzaki S., Canis M., Pouly J.L., Wattiez A., Okamura K., and Mage G. Cyclooxygenase-2 expression in deep endometriosis and matched eutopic endometrium. Fertil Steril 82 (2004) 1309-1315
25. Mihalich A., Reina M., Mangioni S., Ponti E., Alberti L., Vigano P., et al. Different basic fibroblast growth factor and fibroblast growth factor-antisense expression in eutopic endometrial stromal cells derived from women with and without endometriosis. J Clin Endocrinol Metab 88 (2003) 2853-2859
26. Brenner R.M., Nayak N.R., Slayden O.D., Critchley H.O., and Kelly R.W. Premenstrual and menstrual changes in the macaque and human endometrium: relevance to endometriosis. Ann NY Acad Sci 955 (2002) 60-74
27. Deguchi M., Ishiko O., Sumi T., Yoshida H., Yamamoto K., and Ogita S. Expression of angiogenic factors in extrapelvic endometriosis. Oncol Rep 8 (2001) 1317-1319
28. Noble L.S., Takayama K., Zeitoun K.M., Putman J.M., Johns D.A., Hinshelwood M.M., et al. Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells. J Clin Endocrinol Metab 82 (1997) 600-606
29. Hull M.L., Charnock-Jones D.S., Chan C.L., Bruner-Tran K.L., Osteen K.G., Tom B.D., et al. Antiangiogenic agents are effective inhibitors of endometriosis. J Clin Endocrinol Metab 88 (2003) 2889-2899
30. Dogan E., Saygili U., Posaci C., Tuna B., Caliskan S., Altunyurt S., et al. Regression of endometrial explants in rats treated with the cyclooxygenase-2 inhibitor rofecoxib. Fertil Steril 82 (2004) 1115-1120
31. Laschke M.W., Elitzsch A., Scheuer C., Vollmar B., and Menger M.D. Selective cyclo-oxygenase-2 inhibition induces regression of autologous endometrial grafts by down-regulation of vascular endothelial growth factor-mediated angiogenesis and stimulation of caspase-3-dependent apoptosis. Fertil Steril 87 (2007) 163-171
32. Fasciani A., D'Ambrogio G., Bocci G., Luisi S., Artini P.G., and Genazzani A.R. Vascular endothelial growth factor and interleukin-8 in ovarian cystic pathology. Fertil Steril 75 (2001) 1218-1221